Researchers at Texas A&M University have developed a nanotech control device that achieves six degrees of freedom for precise positioning in nanotechnology and telesurgery. The device eliminates mechanical contact and friction, improving accuracy and resolution, while decreasing manufacturing costs and increasing reliability.
Researchers found a link between polycystic ovary syndrome and increased coronary artery calcification, an early indicator of cardiovascular disease. Addressing insulin sensitivity and central obesity may reduce this risk in young women with PCOS.
Research in Italy has successfully engineered seedless eggplants using genetic modification, producing 30-35% more fruit than conventional varieties. The genetically modified eggplants have improved productivity, reduced cultivation costs, and can thrive in cooler conditions.
A recent study found that smoking cessation success rates are equally good with over-the-counter (OTC) or prescription nicotine replacement therapy (NRT). OTC NRT had higher abstinence rates at six weeks and six months compared to prescription NRT. The study suggests that removing the prescription status of NRT products may promote saf...
Researchers found that treated zeolite filters were effective in removing viruses and bacteria from drinking water, achieving 99% virus removal rates. The study suggests using zeolite filters as a low-cost solution for controlling the spread of diseases through contaminated wells.
A team of researchers from UC Davis has developed a simple model to predict the solubility of environmental contaminants in groundwater. The model uses hydrotalcites, layered compounds that can take up metals and other chemicals, to make predictions about contamination with chromium, carbon, iodine, and technetium isotopes.
A new study found that neoadjuvant therapy can significantly improve long-term survival rates for women with locally advanced breast cancer. The treatment allows for less drastic and breast-sparing surgery, increasing the chances of successful tumor downstaging and improved outcomes.
The NIH has granted $3.5 million in funding to four institutions to enhance their human embryonic stem cell (hESC) research infrastructure. The funds will support the expansion, testing, quality assurance, and distribution of existing cell lines, enabling basic scientists to access these cells for research.